Abstract
There remains uncertainty over optimal antithrombotic management strategy for patients with atrial fibrillation (AF) presenting with an acute coronary syndrome and/or undergoing percutaneous coronary intervention/stenting. Clinicians need to balance the risk of stroke and thromboembolism against the risk of recurrent cardiac ischaemia and/or stent thrombosis, and the risk of bleeding. This consensus document comprehensively reviews the published evidence and presents a consensus statement on a 'best practice' antithrombotic therapy guideline for the management of antithrombotic therapy in such AF patients.
Original language | English |
---|---|
Pages (from-to) | 13-28 |
Number of pages | 16 |
Journal | Thrombosis and Haemostasis |
Volume | 103 |
Issue number | 1 |
DOIs | |
Publication status | Published - 1 Jan 2010 |
Keywords
- percutaneous coronary intervention
- acute coronary syndrome
- warfarin
- stenting
- antithrombotic therapy
- Arial fibrillation